“The number of weekly reported deaths from COVID-19 continues to decline, and is now at the lowest level in almost a year.” – WHO Director-General Tedros Adhanom Ghebreyesus. Still far too many people dying from COVID but signs again that things are slowly moving in a more positive direction.
Aspirin lowers risk of COVID: New findings support preliminary Israeli trial
Over-the-counter aspirin could protect the lungs of COVID-19 patients and minimize the need for mechanical ventilation, according to new research at the George Washington University.
The team investigated more than 400 COVID patients from hospitals across the United States who take aspirin unrelated to their COVID disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.
“As we learned about the connection between blood clots and COVID-19, we knew that aspirin – used to prevent stroke and heart attack – could be important for COVID-19 patients,” said Dr. Jonathan Chow of the study team. “Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”